From September 11 to 14, 2024, WEMBLEY MEDICAL participated in Pharmed & Healthcare Vietnam – PHARMEDI Vietnam 2024. This event attracted thousands of experts, industry businesses, and healthcare organizations from around the world. It served as a significant opportunity for WEMBLEY MEDICAL to showcase its advanced medical products, contributing to the growth of the healthcare sector in Vietnam.

Showcasing advanced products and technologies

With extensive experience, WEMBLEY MEDICAL once again reaffirmed its pioneering position in Vietnam's healthcare industry at PHARMEDI Vietnam 2024. By independently manufacturing and introducing high-tech products, particularly in the fields of diagnostics and healthcare, WEMBLEY MEDICAL made a strong impression. The company’s booth garnered significant attention for its unique products, such as safety intravenous catheters, cell-free DNA/RNA preservative vacuum blood collection tubes, PRP platelet rich plasma isolation kit, and more. This not only demonstrated the company’s ability to meet domestic market demands but also opened opportunities for import substitution, contributing to cost savings and enhancing the competitiveness of Vietnam's healthcare sector.

Notably, WEMBLEY MEDICAL's MEDCATH safety intravenous catheter has marked a breakthrough in Vietnam's medical device manufacturing industry. As the first company in Vietnam to independently produce safety IV catheters, WEMBLEY MEDICAL has demonstrated its manufacturing capabilities and product quality. The catheter’s unique three-beveled needle design helps minimize pain and vein damage, providing greater comfort for patients. Additionally, the automatic activation of the safety mechanism not only protects healthcare workers but also prevents cross-contamination, contributing to improved healthcare quality.

Expanding international cooperation and development

Participation in PHARMEDI Vietnam 2024 not only provides WEMBLEY MEDICAL with an opportunity to solidify its strong position in the Vietnamese healthcare market but also opens the door to extensive collaboration with international partners. This event serves as a significant forum for the company to explore new opportunities and engage with leading global healthcare businesses and organizations. With a strategy focused on continuous development, innovation, and product improvement, WEMBLEY MEDICAL aims to establish numerous important strategic partnerships with international partners. These agreements will not only strengthen the company’s position domestically but also represent a significant advancement in expanding its international market, bringing high-quality medical products manufactured in Vietnam to numerous countries around the world.

The company places great emphasis on establishing a sustainable domestic distribution system and ensuring optimal support for global partners in the deployment of high-quality products such as safety intravenous catheters and blood collection tubes. With a long-term vision, WEMBLEY MEDICAL aims not only to export its products but also to share expertise and technology, contributing to the enhancement of global healthcare quality.

Commitment to enhancing Hhlthcare quality

With a long-term and sustainable investment strategy, WEMBLEY MEDICAL aims not only to expand its product portfolio but also to develop a comprehensive healthcare ecosystem, including consulting services, technical support, and customer care. The company is also committed to advancing research projects focused on new medical technologies and products to deliver exceptional value to the healthcare sector, thereby improving the quality of healthcare not only in Vietnam but globally.

Through its presence at international medical exhibitions such as PHARMEDI Vietnam 2024, WEMBLEY MEDICAL clearly demonstrates its commitment to enhancing healthcare quality, not only in Vietnam but also globally. The company’s participation in these events serves not only as an opportunity to showcase its products and technologies but also as a significant step forward in learning and connecting with international partners to promote collaboration in research and development.